Psoriasis: Clinical Trials

32 trials for Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 unknown. 32 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 432Unknown 32

Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Excimer Laser With Topical Agents in Psoriasis Vulgaris
308nm Excimer laser, Tazarotene Topical Gel, Betamethasone Valerate - Psoriasis
Phase 4UnknownAssiut University302022-10-302022-10-18
Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients
Venapuncture, Patient questionnaires - Psoriasis Vulgaris
Phase 4UnknownUniversity Hospital, Ghent1002022-08-222024-01-18
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis
Narrowband ultraviolet B, Methotrexate - Psoriasis
Phase 4UnknownAswan University Hospital302022-01-102022-06-22
Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
topical methotrexate micoemulsion, Excimer light, Narrow band ultraviolet B - Psoriasis, Methotrexate
Phase 4UnknownAssiut University302021-10-012021-07-21
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
Etanercept, OCT - Psoriasis, Psoriatic Arthritis
Phase 4UnknownOptiSkin Medical102021-08-092022-01-06
Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .
Acitretin 25Mg Cap, Narrowband ultraviolet B - Psoriasis
Phase 4UnknownSouth Valley University302021-06-052022-06-02
Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults
Benvitimod - Psoriasis
Phase 4UnknownPeking University People's Hospital20002021-06-012021-10-01
Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity
SKYRIZI - Psoriasis
Phase 4UnknownIstituto Clinico Humanitas2402021-01-252021-01-29
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis
Narrowband ultraviolet B, Methotrexate - Psoriasis
Phase 4UnknownAswan University Hospital302020-12-132021-03-23
Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome
Secukinumab, Methotrexate - Psoriasis, Metabolic Syndrome
Phase 4UnknownUniversita di Verona702020-08-012020-07-14
The Maintenance Effect of Enstilar Foam in Combination With Otezla
Apremilast 30mg, calcipotriene and betamethasone dipropionate - Psoriasis
Phase 4UnknownDerm Research, PLLC302020-06-242020-10-09
Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)
Venapuncture, Patient questionnaires - Psoriasis Vulgaris
Phase 4UnknownUniversity Hospital, Ghent1002020-04-052024-02-05
Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients
Methotrexate, Vitamin D - Psoriasis
Phase 4UnknownCairo University302019-04-012019-04-05
EBIO - Enthesitis Biopsy Study
Secukinumab - Psoriatic Arthritis, Enthesitis
Phase 4UnknownUniversity of Erlangen-Nürnberg Medical School102019-03-182022-01-28
Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP)
Apremilast Oral Tablet - Psoriasis, Psoriatic Arthritis
Phase 4UnknownProfessor Mikkel Østergaard1152018-12-142020-08-17
Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis
Brodalumab, Placebos - Psoriasis
Phase 4UnknownAarhus University Hospital502018-09-152019-07-10
Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism
Metformin - Psoriasis Vulgaris With Metabolic Disorders
Phase 4UnknownCentral South University802018-09-012018-08-14
Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker
Abatacept 125 MG/ML - Evaluate Bone Changes in Patients With PsA
Phase 4UnknownUniversity of Erlangen-Nürnberg Medical School202018-06-062019-09-27
Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis
Apremilast and Clobetasol - Psoriasis
Phase 4UnknownWashington Dermatology Center202018-02-252018-03-05
Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
fractional carbon dioxide laser, Tazarotene Cream 0.1% - Nail Psoriasis
Phase 4UnknownAssiut University302017-10-012017-08-28

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Arthritis, Psoriatic (6)  ·  Acne Vulgaris (1)  ·  Arthritis, Rheumatoid (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypertension (1)  ·  Leprosy (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)  ·  Pneumonia, Pneumocystis (1)  ·  Skin Diseases, Vesiculobullous (1)  ·  Spondylitis, Ankylosing (1)  ·  Tuberculosis (1)  ·  Urticaria (1)

Broader conditions

Skin Diseases (32)  ·  Skin Diseases, Papulosquamous (32)  ·  Skin and Connective Tissue Diseases (32)  ·  Arthritis (6)  ·  Bone Diseases (6)  ·  Joint Diseases (6)  ·  Musculoskeletal Diseases (6)  ·  Spinal Diseases (6)  ·  Spondylarthritis (6)  ·  Spondylarthropathies (6)  ·  Spondylitis (6)  ·  Nutritional and Metabolic Diseases (3)  ·  Actinomycetales Infections (2)  ·  Bacterial Infections (2)

Interventions

Etanercept (5)  ·  Methotrexate (4)  ·  apremilast (4)  ·  Acitretin (3)  ·  Adalimumab (3)  ·  secukinumab (3)  ·  Infliximab (2)  ·  Abatacept (1)  ·  Adrenocorticotropic Hormone (1)  ·  Betamethasone Valerate (1)  ·  Capsules (1)  ·  Certolizumab Pegol (1)  ·  Clobetasol (1)  ·  Cyclosporine (1)  ·  Dapsone (1)

Sponsors

Assiut University (3)  ·  Universita di Verona (3)  ·  Aswan University Hospital (2)  ·  University Hospital, Ghent (2)  ·  University of Erlangen-Nürnberg Medical School (2)  ·  Aarhus University Hospital (1)  ·  Cairo University (1)  ·  Central South University (1)  ·  Derm Research, PLLC (1)  ·  Fiechtner, Justus J., M.D., P.C. (1)  ·  Florida Academic Dermatology Centers (1)  ·  Frankel, Amylynne, M.D. (1)  ·  Istituto Clinico Humanitas (1)  ·  Jagiellonian University (1)  ·  Medical University of Vienna (1)

Countries

United States (6)  ·  Egypt (3)  ·  Italy (3)  ·  Belgium (2)  ·  China (2)  ·  Denmark (2)  ·  Germany (2)  ·  Austria (1)  ·  Greece (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Poland (1)

Top investigators

Adrian Tanew, MD (1)  ·  Bogdan Batko, MD, PhD (1)  ·  Furen Zhang (1)  ·  Giampiero Girolomoni (1)  ·  Giampiero Girolomoni, Professor (1)  ·  Ignatios Ikonomidis, Dr (1)  ·  Jo Lambert, Prof (1)  ·  Jo Lambert, Prof. (1)  ·  L.H. Kircik, M.D. (1)  ·  Markus Neurath, Prof (1)  ·  Mayke BG Koek, MD, M.Sc. (1)  ·  Moustafa A El Taieb (1)  ·  Moustafa A El Taieb, Professor (1)  ·  Orit Markowitz, MD (1)

Results publications

PMID 15389191, PMID 29448838, PMID 12810507, PMID 15787822, PMID 16882343, PMID 19043379, PMID 19423623, PMID 20406865, PMID 20857129, PMID 20858386, PMID 21284407, PMID 25606333, PMID 25645671, PMID 27174314, PMID 28232140, PMID 28785349, PMID 28899951, PMID 29387603, PMID 29442137, PMID 31850114, PMID 32129962, PMID 32508993, PMID 32738429, PMID 33352561, PMID 34819613

NIH funding

2016 (1)